Adjuvantno zdravljenje raka debelega črevesa

Show document
A+ | A- | | SLO | ENG

Title:	Adjuvantno zdravljenje raka debelega črevesa
Authors:	ID Ocvirk, Janja (Author)
Files:	PDF - Presentation file, download (301,75 KB) MD5: 665E4813B0D5D0093DBB33D99EC412AC PID: 20.500.12556/dirros/46094599-a97f-4935-98ed-4078b24d5528
Language:	Slovenian
Typology:	1.08 - Published Scientific Conference Contribution
Organization:	OI - Institute of Oncology
Abstract:	Incidenca raka debelega črevesa še vedno narašča. Odkrit v zgodnjem stadiju je ozdravljiva bolezen že s samo kirurškim posegom. Pri bolnikih stadija I in večini stadija II je operacija dovolj ter ne potrebujejo dodatnega zdravljenja. Bolniki stadija III potrebujejo dodatno zdravljenje z adjuvantno kemoterapijo, saj ta zmanjša število ponovitev bolezni in s tem podaljša celotno preživetje ter vodi k večjemu številu ozdravljenih bolnikov. Glede na rezultate nedavnih raziskav pa tudi bolnikom stadija II glede na prisotnost rizičnih dejavnikov priporočamo zdravljenje z adjuvantno kemoterapijo.
Keywords:	adjvantno zdravljenje, rak debelega črevesa, rak danke, rak prebavil
Publication status:	Published
Publication version:	Version of Record
Year of publishing:	2013
Number of pages:	str. 35-36, 75
Numbering:	Letn. 17, št. 1
PID:	20.500.12556/DiRROS-8659
UDC:	616.3-006-08
ISSN on article:	1408-1741
URN:	URN:NBN:SI:doc-2HLK7W6A
COBISS.SI-ID:	1554555
Copyright:	by Authors
Publication date in DiRROS:	31.08.2018
Views:	3393
Downloads:	760
Metadata:
:	Copy citation

Share:

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Title:	Šola tumorjev prebavil, Ljubljana, 30. 11. 2012
Publisher:	Onkološki inštitut
COBISS.SI-ID:	1553275

License:	CC BY 4.0, Creative Commons Attribution 4.0 International

Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Language:	English
Title:	Adjuvant treatment of colon cancer
Abstract:	The incidence of colon cancer is still increasing. If detected at an early stage, it is already curable by surgery alone. In patients with stage I disease and in the majority of patients with stage II disease, surgery is sufficient, and no additional treatment is required. However, stage III patients require additional treatment with adjuvant chemotherapy, as the latter reduces the number of disease recurrences, thus prolonging the overall survival and leading to a larger number of cured patients. Considering the results of the recent studies, stage II patients are also recommended to undergo adjuvant chemotherapy, depending on the presence of risk factors.